Chinese Second Hip Fracture Evaluation
NCT03461237 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 3000
Last updated 2025-08-17
Summary
1. To Compare overall rates of second hip fractures in both genders,
2. To determine the effect of hip fracture on proximal femoral volumetric bone mineral density (vBMD), bone structure and muscle by quantitative computed tomography(QCT),
3. To evaluate the contribution of QCT-image analysis to the prediction of the second hip fracture risk.
4. To identify the differences between femoral neck fracture and trochanter fracture following hip fracture
Conditions
- Hip Fractures
- Osteoporosis
Sponsors & Collaborators
-
Beijing Jishuitan Hospital
lead OTHER
Principal Investigators
-
Xiaoguang Cheng, MD · department of radiology, Beijing Jishuitan Hospital
Eligibility
- Min Age
- 50 Years
- Max Age
- 95 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2017-05-01
- Primary Completion
- 2026-05-31
- Completion
- 2026-11-30
Countries
- China
Study Locations
More Related Trials
-
Influence of PET/CT Radiomic Features on the Outcome of Lung Cancer Patients
NCT03648151 ·Status: COMPLETED
-
MRI-based Clinico-radiomics Predicting Lymph Node Metastasis Status of Hilar Cholangiocarcinoma
NCT05626127 ·Status: UNKNOWN
-
18F-AlF-FAPi-04 PET/CT Imaging in Patients With Solid Tumor
NCT06126705 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
Diagnostic Performance and Safety of 18F-NaF-PET/CT in Bone Metastases Compared With 99mTc⁃MDP-BS±SPECT
NCT05614518 ·Status: COMPLETED ·Phase: PHASE3
-
PET-CT in Lymphoma Among the Eldery
NCT07259941 ·Status: NOT_YET_RECRUITING
-
Positron Nuclide Labeled DOTA-FAPI PET Study in Colocrectal Cancer
NCT04750772 ·Status: UNKNOWN ·Phase: NA
-
A Study Evaluating the Value of 68Ga-Pentixafor PET Imaging in the Staging of Hematological Tumor, and Comparing It with 18F-FDG PET/CT Imaging
NCT06834412 ·Status: RECRUITING ·Phase: NA
-
Comaprison of 68Ga-FAP-2286 and 18F-FDG PET/CT in Patients With Various Types of Cancer
NCT05392205 ·Status: COMPLETED ·Phase: NA
-
Comparing 18F-FAPI-04 and 18F-FDG PET/CT in Cancer Detection
NCT06206642 ·Status: COMPLETED ·Phase: NA
-
Dual Energy Computed Tomography (CT) in Finding Bone Metastases in Patients With Cancer
NCT02354326 ·Status: TERMINATED
-
Two Bed SPECT/CT Versus Planar Bone Scintigraphy in Detection of Osseous Metastases in Patients With Genitourinary Malignancies
NCT05597215 ·Status: UNKNOWN
-
[68Ga]Ga-P15-041 PET/CT in Variety of Bone Tumors
NCT06455722 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
Using FDG-PET/CT to Assess Response of Bone-Dominant Metastatic Breast Cancer, FEATURE Study
NCT04316117 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
A Feasibility Study to Determine PET/CT Imaging of Blood Flow to the Bone
NCT03557450 ·Status: COMPLETED ·Phase: NA
-
Multi-parametric MRI and Dual-energy CT in Patients of Gastric Cancer
NCT05508126 ·Status: RECRUITING
-
68Ga-DOTA-hLAG-3 PET Imaging of LAG-3 Expression in Cancers
NCT05346276 ·Status: COMPLETED
-
Evaluation of PET/MR and PET/CT Imaging for Bone Marrow Lesions
NCT01880762 ·Status: COMPLETED
-
Comparison of 68Ga-DOTA-FAPI-46 and 68Ga-DOTA-2P(FAPI)2 PET/CT in Patients With Various Types of Cancer
NCT04941872 ·Status: COMPLETED ·Phase: NA
-
PET in Guiding Cervical Lymphadenectomy (ECTOP-2003)
NCT03244566 ·Status: COMPLETED
-
Defining PET / CT Protocols With Optimized F18-FDG (Fluorodeoxyglucose) Dose, Focusing on Reduced Radiation Dose and Improved Image Quality
NCT02378337 ·Status: COMPLETED
-
Absolute Quantification in Bone Scintigraphy
NCT04671238 ·Status: COMPLETED
-
Evaluating the Usefulness of 18F-AlF-FAPI PET/ CT in Orbital Neoplasms
NCT06791226 ·Status: RECRUITING ·Phase: NA
-
Detection of Functioning Pituitary Microadenoma: PET/MRI Versus PET/CT
NCT03404414 ·Status: UNKNOWN ·Phase: PHASE1
-
A Study of the Clinical Application of [18F]RCCB6 and [68Ga]Ga-NOTA-RCCB6 PET/CT Imaging in the Diagnosis of CD70-expressing Multiple Tumors
NCT06148220 ·Status: RECRUITING ·Phase: NA
-
Usefulness of 18F-FDG PET/CT in the Initial Staging and Surveillance of Endometrial Cancer Patients
NCT05056259 ·Status: UNKNOWN